Clinical Trial: Weight Loss Study: Genetics and Response to Naltrexone/Bupropion
Study Status: Completed
Recruit Status: RECRUITING
Condition: Obesity
Study Type: INTERVENTIONAL
Official Title: Association of Genetic Variations and Weight Loss Response to Naltrexone/Bupropion
Brief Summary:
The goal of this clinical trial is to understand if genetic variations are associated with the amount of weight loss with diet and while taking an FDA-approved medication for weight loss.The main question[s] it aims to answer are:In Aim One, the investigators propose to rigorously test the hypothesis that presence of the Taq1A A1+ polymorphism is associated with greater weight loss with NB compared with the A1- genotype.In Aim Two, the investigators will explore other genetic polymorphisms that might influence the…
Read more